About Novo Nordisk Pharma, Brussels
Novo Nordisk Pharma, Brussels: A Leading Force in the Fight Against Chronic Diseases
Novo Nordisk België is a subsidiary of Novo Nordisk, a global healthcare company with more than 90 years of innovation and leadership in diabetes care. The company's mission is to defeat diabetes and other serious chronic diseases such as obesity, hemophilia, growth disorders, and rare bleeding disorders.
With its headquarters in Denmark, Novo Nordisk has operations in more than 80 countries worldwide. In Belgium, the company has been present since 1956 and has established itself as a leading force in the fight against chronic diseases.
Diabetes is one of the most pressing health challenges facing our society today. According to the International Diabetes Federation (IDF), there are currently over 463 million people living with diabetes worldwide. In Belgium alone, it is estimated that around 1 million people have diabetes.
Novo Nordisk België offers a range of innovative solutions for people living with diabetes. These include insulin products such as Levemir®, Novorapid®, Tresiba® and Xultophy®, as well as GLP-1 receptor agonists like Ozempic® and Rybelsus® which help to lower blood sugar levels while also promoting weight loss.
In addition to its focus on diabetes care, Novo Nordisk België also provides treatments for other serious chronic conditions such as hemophilia A & B (ReFacto AF®, Novoeight®) , growth hormone deficiency (Norditropin SimpleXx®), rare bleeding disorders (Novoseven RT ®) , obesity (Saxenda ®) , among others.
The company's commitment to research and development has led to numerous breakthroughs in medical science over the years. For example, Novo Nordisk was one of the first companies to develop human insulin using recombinant DNA technology back in the early 1980s. Since then they have continued their pioneering work by developing new classes of drugs that target specific pathways involved in disease progression.
At Novo Nordisk België they believe that collaboration between patients, healthcare professionals and industry partners is key to improving patient outcomes. They work closely with these stakeholders through various initiatives aimed at raising awareness about chronic diseases like Diabetes through educational programs for patients & HCPs alike .
The company also supports various patient organizations across Belgium including Diabetes Liga vzw/asbl which aims at providing support services for people living with Diabetes across Belgium .
In conclusion,
Novo Nordisk Pharma Brussels' unwavering commitment towards defeating chronic diseases makes them an invaluable partner for patients suffering from these conditions across Belgium . With their innovative solutions backed by cutting-edge research & development efforts coupled with their collaborative approach towards patient care - they are truly making a difference!